Basic Information
| LncRNA/CircRNA Name | anti-NOS2A |
| Synonyms | NOS2, HEP-NOS, INOS, NOS, NOS2A |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioblastoma |
| ICD-0-3 | NA |
| Methods | qPCR etc. |
| Sample | glioblastoma tissues |
| Expression Pattern | up-regulated |
| Function Description | We show that this antisense transcript (anti-NOS2A RNA) is expressed in different types of brain tumors, including meningiomas and glioblastomas. |
| Pubmed ID | 18820242 |
| Year | 2008 |
| Title | Novel noncoding antisense RNA transcribed from human anti-NOS2A locus is differentially regulated during neuronal differentiation of embryonic stem cells. |
External Links
| Links for anti-NOS2A | GenBank HGNC NONCODE |
| Links for glioblastoma | OMIM COSMIC |